April 4, 2024
Global Market Comments April 4, 2024 Fiat Lux Featured Trade: (A NOTE ON OPTIONS CALLED AWAY), (FCX), (XOM), (OXY), (WPM), (TSLA)
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 3303 entries already.
Global Market Comments April 4, 2024 Fiat Lux Featured Trade: (A NOTE ON OPTIONS CALLED AWAY), (FCX), (XOM), (OXY), (WPM), (TSLA)
Occasionally, I get a call from Concierge members asking what to do when their short position options are assigned or called away. The answer was very simple: fall down on your knees and thank your lucky stars. You have just made the maximum possible profit for your position instantly. We have the good fortune to
Mad Hedge Technology Letter April 3, 2024 Fiat Lux Featured Trade: (TESLA ON THE BACK FOOT) (TSLA)
Peak Tesla? It sure seems like it. I don’t want to jinx the company, but it is highly likely that it is passed its best. The data is looking increasingly gloomy and could set the stage for an even larger drop into irrelevance. In short, it’s definitely not looking too bright for the company that
“I definitely fall into the camp of thinking of AI as augmenting human capability and capacity.” – Said Microsoft CEO Satya Nadella
(ANALYSTS AND INVESTORS ARE STARTING TO PAY ATTENTION TO THE ENERGY SECTOR) April 3, 2024 Hello everyone. The month of April is upon us, and the market environment has turned a little cloudy. Economic data and heightened geopolitical risks appear to be fuelling the move higher in Oil prices. With the new month,
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Biotech and Healthcare Letter April 2, 2024 Fiat Lux Featured Trade: (BREATHE EASY) (MRK), (JNJ)
It looks like Merck (MRK) just scored a major touchdown in the drug wars, which might make the looming Keytruda patent expiration sting a little less. Remember when Merck dropped $11.5 billion on Acceleron back in 2021 to get their hands on Winrevair (then known as Sotatercept)? That was a seriously gutsy move to soften
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.
